Kimberly-Clark Completes Kenvue Acquisition, Expands Health
DALLAS, Texas, U.S., November 2, 2026 Kimberly-Clark Corporation has completed its acquisition of Kenvue Inc., creating a major global...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
DALLAS, Texas, U.S., November 2, 2026 Kimberly-Clark Corporation has completed its acquisition of Kenvue Inc., creating a major global...
Vancouver, British Columbia, September 23, 2026 Zymeworks Inc. has completed its previously announced acquisition of Theravance Biopharma, Inc., bringing...
Melbourne, Australia; Indianapolis, U.S.; Munich, Germany, September 21, 2026 Telix Pharmaceuticals Limited has announced a strategic agreement to lead...
LIBERTY CORNER, N.J. — September 17, 2026 Lisata Therapeutics announced the acquisition of Marea Therapeutics, combining the companies to...
TORONTO, Canada and GERMANTOWN, Maryland — September 8, 2026 Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. announced a definitive...
Las Vegas, Nevada, USA, September 7, 2026 The community-acquired bacterial pneumonia (CABP) treatment market is expected to expand through...
Silver Spring, Maryland, USA, September 5, 2026 The U.S. Food and Drug Administration (FDA) has announced steps intended to...
Boston, Massachusetts, USA, September 1, 2026 Vertex Pharmaceuticals Incorporated has completed its acquisition of Crinetics Pharmaceuticals, Inc., strengthening its...
Amsterdam, the Netherlands – August 27, 2026 argenx announced the successful completion of its acquisition of Forte Biosciences, Inc.,...
San Diego, California / Alderley Park, United Kingdom — August 14, 2026 Skye Bioscience, Inc. and Redx Pharma Limited...
